Oramed Pharmaceuticals Inc.
$4.69
$0.07 (+1.52%)
$4.65Day Range$4.77
Key Statistics
Market Cap
$192.18M
Shares Outstanding
41.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 19, 2004
Round Lot
100
Locale
US
Trading Data
Day Open
$4.70
Day High
$4.77
Day Low
$4.65
Volume
99.0K
VWAP
$4.69
Prev Close
$4.62
Transactions
--
Acc. Volume
--
About Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
PHARMACEUTICAL PREPARATIONSSIC 283413 employees1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036646-844-1164IPO Apr 19, 2004US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001176309
- Composite FIGI
- BBG000LRYR36
- Share Class FIGI
- BBG001SK4M90
- Ticker Root
- ORMP
- SIC Code
- 2834
About Oramed Pharmaceuticals Inc. (ORMP) Stock
Oramed Pharmaceuticals Inc. (ORMP) closed the 2026-09-17 session at $4.69, up 1.52% versus the previous close (+0.07). The stock opened at $4.70 and traded between $4.65 and $4.77 during that session. Session trading volume was 99K shares. The volume-weighted average price (VWAP) is $4.69.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
Oramed Pharmaceuticals Inc. has a market capitalization of $192.2 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ORMP is listed on the XNAS exchange. The company employs approximately 13 people. Oramed Pharmaceuticals Inc. is headquartered in NEW YORK, NY. The recorded listing date is 2004-04-19.
On this page you can find market ORMP stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.